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Abstract
Representing a renewable source for cell replacement, neural stem cells have received substantial attention in recent years.
The neurosphere assay represents a method to detect the presence of neural stem cells, however owing to a deficiency of
specific and definitive markers to identify them, their quantification and the rate they expand is still indefinite. Here we
propose a mathematical interpretation of the neurosphere assay allowing actual measurement of neural stem cell
symmetric division frequency. The algorithm of the modeling demonstrates a direct correlation between the overall cell fold
expansion over time measured in the sphere assay and the rate stem cells expand via symmetric division. The model offers a
methodology to evaluate specifically the effect of diseases and treatments on neural stem cell activity and function. Not
only providing new insights in the evaluation of the kinetic features of neural stem cells, our modeling further contemplates
cancer biology as cancer stem-like cells have been suggested to maintain tumor growth as somatic stem cells maintain
tissue homeostasis. Indeed, tumor stem cell’s resistance to therapy makes these cells a necessary target for effective
treatment. The neurosphere assay mathematical model presented here allows the assessment of the rate malignant stem-
like cells expand via symmetric division and the evaluation of the effects of therapeutics on the self-renewal and
proliferative activity of this clinically relevant population that drive tumor growth and recurrence.
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Introduction
Traditionally, stem cells were thought to be located only in
tissues where differentiated cells were most susceptible to loss and
the need for replacement great, such as the skin [1], intestinal
epithelia [2] and the blood [3]. Since the adult central nervous
system (CNS) was considered to lack a significant amount of
neuronal death, and have no regenerative capacity, the existence
of neural stem cells (NSC) seemed both unlikely, and unnecessary.
However, in 1992 the existence of NSCs within the adult
mammalian CNS with the ability to give rise to new neurons
was demonstrated [4]. Like stem cells found in other tissues, NSCs
(which line the entire ventricular neuroaxis of the adult
mammalian CNS [4,5]) exhibit the defining in vitro stem cell
characteristics [2,6] of proliferation, extensive self-renewal,
generation of a large number of progeny, and multi-lineage
differentiation potential as well as the in vivo characteristic of
regenerating tissue after injury [4,7,8]. Adult stem cells represent a
relatively quiescent reservoir of uncommitted cells. These cells
have the ability to divide throughout the lifespan of the organism
to give rise to more committed progenitor cells generating a large
number of undifferentiated cells. These progenitors ultimately
differentiate into lineage-restricted functional cells. Due to their
ability to give rise to new cells, the factors regulating the division of
stem and progenitor cells, and the differentiation of their progeny
is of great interest in treating CNS disorders resulting from the loss
or inappropriate functioning of cells. Therefore, the development
of tools enabling stem cell-specific study represents a formidable
challenge. Stem cells are difficult to visually define, as there exists
no well-accepted positive marker. As a result these cells are defined
based on a functional definition. While employing a functional
read-out has made it possible to identify the presence (or absence)
of stem cells in a population, it unfortunately prohibits the direct
isolation or discrimination of stem cells from non-stem cells
thereby precluding any meaningful quantitative data pertaining to
their frequency and/or expansion rate.
A growing body of evidence supports the hypothesis that a
population of tumor-initiating cells (TICs), which exhibit biolog-
ical properties similar to normal somatic stem cells, maintains
malignant tumors. TICs are postulated to reside in acute myeloid
leukaemia [9], as well as in breast [10,11], prostate [12], lung and
mesenchymal tumors [13]. Importantly, neural TICs have also
been isolated and found to exhibit very similar functional
properties to neural stem cells [14,15,16,17]. The so-called cancer
stem cell model suggests that it is these stem cell characteristics that
make the TICs resistant to treatment and drive the tumor
recurrence. As a result these cells represent an essential target for
effective anticancer therapy. Therefore development of methods
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design of innovative treatments targeting this specific cell
population.
In the CNS, one of the methods to isolate and expand somatic
and cancer stem cells is the neurosphere assay (NSA) [4,14,15,18].
Of interest and attesting to its robustness, the free-floating sphere
culture system is also used to study amongst others, breast cancer
stem cells [11,19]. However, while the NSA is an appropriate
method to identify stem cell activity, we contend that the enume-
ration of spheres is not appropriate to measure stem cell frequency
or expansion rate as doing so results in an overestimation [20,21].
The current study presents the development, validation and
application of a method enabling specifically quantification of
somatic and cancer stem cell symmetric division rate using free
floating sphere assay.
Results
Thought experiment
Unlike the culturing and passaging of most lines where the
majority of cells survive disaggregation and go on to proliferate
until the culture becomes confluent, during passaging in the NSA,
the majority (.90%) of the cells die or do not further proliferate.
This is supported by the fact that during one passage the majority
of the dividing cells give rise to at least 256 progenies by
undergoing a minimum of eight cell divisions (data not shown).
This would result in a 256-fold expansion at each passage if every
single plated cell were growth factor-responsive and divided 8
times. However our experiments described below show a cellular
fold expansion between 1 and 20 with the different cell types we
used. These data, together with published clonality data [20,21,22]
demonstrate that less than 10% of the cells plated in the NSA
contribute to the overall population expansion. Therefore only the
surviving fraction of growth factor-responsive sphere-forming cells
divide, form spheres, and renew the founding population. Cell
death notwithstanding, during each passage, there is a geometric
increase in the number of cells that are generated. Typically, if
100,000 cells are plated, greater than 90,000 of the cells die within
the first 24–48 hours, leaving 10,000 cells to proliferate, form
spheres and ultimately generate about 500,000 cells. This 5-fold
expansion tends to be fairly consistent when passing cells over time
and never shows a time-dependent escalation in fold expansion
(i.e. 5-fold, 7-fold, 8-fold etc.) [23]. Moreover, each individual
neurosphere line is essentially unique with regards to the fold-
increase in the number of cells generated from passage to passage
(some lines may show a 5-fold expansion while others a 6 or 4-fold
expansion), but consistent within the particular line.
The ability to indefinitely serially passaged NSCs [23] and the
fact that most of the cells die or stop proliferating at each passage,
indicates that the population must be maintained by a long-term
proliferating cell(s) (by definition a cell with stem cell features). We
content thatthe frequencyoflong-termproliferating(LTP)cells(aka
NSCs) will be reflected in the rate at which the population expands
(i.e. fold increase from passage to passage) and this is reflected in the
slope of the growth curve. In order to understand how self-renewing
symmetric divisions of LTP cells affect the growth curve, consider
the following thought experiment (Figure 1).
(Figure 1a) In the case of a LTP cell that generates a sphere of
1000 cells without undergoing any symmetric cell divisions, the
resulting sphere will contain only a single LTP cell. Upon a
subsequent passage, all the cells will again die or not participate
to the culture expansion except for the single LTP cell, which
survives, divides, and forms a new sphere. As we continue to
passage this sphere (or population of cells) in this manner we
would observe a 1-fold expansion, which is represented by a
flat growth curve as seen in Figure 1a(i).
Nowconsider that a single LTPcell undergoes one self-renewing
symmetric cell division as it generates a sphere of 1000 cells. In
this case the sphere would have 2 LTP cells. Upon a subsequent
passage, 998 of the cells would die and each of the two LTP cells
would give rise to a sphere of 1000 cells. This doubling of the
total number of spheres (and thus cells) would continue, giving a
growth curve that looks like Figure 1a(ii).
Finally, if we consider that the LTP cell undergoes 3 symmetric
divisions giving rise to 4 LTP cells and 996 non-LTP cells, this
would produce a 4-fold expansion at each passage and a
growth curve that would be expressed as in Figure 1a(iii).
(Figure 1b) If we now keep the number of LTP cells in a sphere
constant (say, 4) and with each iteration change the total cells
generated per sphere from 1000 (i) to 2000 (ii) to 4000 (iii), we find
that the elevation of the growth curve is affected but not its slope
(as seen by an unchanged fold expansion). This indicates that the
total number of cells generated does influence the graph but not
the slope of the growth curve.
Therefore, the cell fold expansion, represented by the slope of
the growth curve, reflects the rate at which the LTP cells expand.
Given that the LTP cell expansion rate is a direct indication of the
numbers of self-renewing symmetric cell divisions, it follows that
the fold expansion or slope can be used to predict LTP (or stem)
cell self-renewing symmetric division.
Mathematical modeling
Assumptions. Here we propose a mathematical model that
allows one to quantify self-renewing symmetric stem cell division
in tissue culture.
We break the class of all possible cells into two types (i) dividing
cells and (ii) non-dividing (ND) cells. Examples of ND cells are cells
that have fully differentiated or cells that have died. We further
break the class of dividing cells into two subtypes, long-term
proliferating (LTP) cells and short-term proliferating (STP) cells.
The lifetime of the LTP cells is defined to be infinite, and in the
context of an experimental setting, means that the lifetime is longer
than that of the experiment. The products of a LTP cell division are
assumed to be either two LTP cells (symmetric self-renewing
division) or a LTP cell and a STP cell (asymmetric cell division). We
assume the LTP cell differentiative symmetric division rate
(LTPRSTP+STP) to be null in the original growing conditions of
the assay. We further assume that during the experiment time the
survival and self-renewing properties of the LTP cells is definite and
stable (defined by a steady state as discussed below).
The lifetime of the STP cells is defined to be finite, which in the
context of an experimental setting, means that the lifetime is
significantly shorter than that of the experiment. The products of a
STP cell division are assumed to be any binary combination of
STP cells and ND cells. It should be emphasized that this
specifically excludes STP cell division from producing a LTP cell.
We further assume that any dividing cell, when placed in the
correct environment, will proceed through its cell cycle and
eventually divide, in a manner that is independent of the presence
of other cells. The products of the cell division will adhere and the
cell cycle continues for all dividing cells. After time, a cluster of
cells, hereafter referred to as a sphere, will have developed.
Importantly, these assumptions imply that a sphere originating
from a STP cell will contain STP cells and ND cells, while a sphere
originating from a LTP cell will contain LTP cells, STP cells and
ND cells.
Stem Cell Symmetric Division and Sphere Assays
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the spheres into the individual constituents (i.e. cells). A fraction of
these constituent cells are then randomly sampled and seeded into
a new flask containing an environment permissive for cell division
(Figure 1). Here we assume that LTP cells are stem-like cells, while
STP cells are more restricted progenitor cells. Hence, the long-
term expansion of the population depends directly on the
expansion of LTP and not STP cells. We previously demonstrat-
ed that 95% of the spheres in the NSA cannot be passed more
than 4 or 6 times suggesting the majority of the spheres are
derived from STP cells and that LTP cells exhibit a higher
proliferative potential [20,21]. Therefore, to accurately define a
population of cells as containing stem-like (i.e. LTP) cells the
overall time-course of the experiment needs to span greater than 4
to 6 passages.
Direct modeling of the Neurosphere Assay. After a few
initial passages (corresponding to a ‘‘recovery period’’ if starting
with freshly dissected primary tissue), the dissociating, plating, and
growing of spheres in bulk culture will become consistent as the
process reaches a stable state that reflects a complex equilibrium
between cell survival, death, proliferation and differentiation. That
is, an initial number of cells are seeded (e.g., 2.5610
5), which
generate spheres and produce a total cell count for the flask (e.g.,
1610
6), a portion of which are harvested (e.g., 25% are taken) and
used to seed another flask for passage. The measurable quantities
are the cell count at the start of the passage, Ti, and the cell count
at the end of the passage, Tf. The fold expansion, F, is calculated
by
F~
Tf
Ti
After the adaptation period of the cells to culture conditions,
when the experiment has entered into the stable state, F is constant
within the limits of experimental error. If the state is stable then it
must also be true that the initial numbers of LTP, STP and ND
cells are the same for every passage. Similarly, the final numbers
must be the same for every passage. Furthermore these cell types
must be undergoing the same overall fold expansion, i.e.,
Figure 1. Thought paradigm. (a): Numerical simulation of stem/progenitor cells growth. As the number of stem cells (i.e. LTP cells) generated in a
clonally derived sphere is increased, the overall fold expansion and the slope of the growth curve are increased as well. (b): If the numbers of stem
(LTP) cells within a sphere is kept constant and the total number of cells within a sphere is doubled (ii) or quadrupled (iii), neither the fold expansion
nor the slope of the growth curve are changed however the curve is elevated. LTP, long-term proliferating cells; STP, short-term proliferating cells;
ND, non-dividing cells.
doi:10.1371/journal.pone.0015844.g001
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Since LTP cells can only be created from LTP cells, and every
LTP cell forms a sphere, then it must also be true, that on average,
there are F LTP cells in every LTP derived sphere. That is, the
number of LTP cells created in an LTP originated sphere (defined
to be l) must be given by, l=F .
The same analysis cannot be applied to STP cells because both
LTP and STP cells produce STP cells. Similarly, the same analysis
cannot be applied to ND cells. As such, data analysis becomes a
matter of measuring the cell counts at the start and end of each
passage, dividing the two to provide a fold expansion, then
averaging the fold expansions of passages in the stable state. By
definition, this average is equivalent to the number of LTP (i.e.
NSCs) cells in an LTP-derived sphere. Therefore, this methodol-
ogy should accurately reflect the frequency of stem-like cells in
stem-like cell derived spheres.
LTP self-renewing symmetric division rate. The smallest
time unit in the above model is a single passage. We now derive a
model for the intra-passage LTP cell numbers. As noted
previously, LTP cell division has two possible outcomes (i) a self-
renewing symmetric division (LTPRLTP+LTP) or (ii) an
asymmetric division (LTPRLTP+STP). We denote the
probability of the first outcome by pll and the second outcome
by pls. Since there are no other possible outcomes, the sum of these
two probabilities must be unity. Let the cell cycle time of the LTP
cells be denoted by cl. The probability of a symmetric cell division
per unit time is thus pll/cl. This can also be interpreted as the rate
of LTP cell symmetric division and we will denote it by Kll. Since
only LTP cells produce LTP cells, the rate of growth of LTP cell
numbers is proportional to the current total numbers of LTP cells.
It should also be noted that an asymmetric division does not
change the total LTP cell numbers. The rate of growth of LTP cell
numbers can thus be expressed as
dLTP t ðÞ
dt
~
Pll
Cl
LTP t ðÞ
This expression can be solved to express the absolute numbers
of LTP cells at a time t,
LTP t ðÞ ~LTP 0 ðÞ e
Pll
Cl
t
It is now possible to equate this model with the above direct
model. For a passage starting at t=0 and finishing at t=tf,
LTP tf

LTP 0 ðÞ
~e
Pll
Cl
tf ~F
Rearranging this expression yields a method of calculating the
rate of LTP cell symmetric division
Kll~
ln F ðÞ
tf
That is, the rate of LTP cell self-renewing symmetric division
can be calculated by taking the natural logarithm of the fold
expansion and dividing by the passage time. Therefore, changes in
the fold expansion (slope of the growth curve) reflect modifications
in the LTP (i.e. stem) cell frequency by variations in their self-
renewing symmetric cell division rate.
Validation of the model using the Neural Colony Forming
Cell Assay (N-CFCA)
Similar to NSCs (LTP cells), progenitor (STP) cells have the
ability to proliferate, and generate progeny that can be
differentiated into functional cells. However, unlike stem cells,
progenitor cells have a more limited proliferation potential
overtime. The recently developed neural colony-forming cell
assay (N-CFCA) exploits these differences in proliferative ability,
enabling one to discriminate NSCs from progenitors based on the
size of colonies they produce when transferred to culture [21].
Consistent with the assumption that progenitor cells exhibit
limited proliferative capacity compared to stem cells, and that the
size (diameter) of the colony can be used to distinguish its founder
cell type, we demonstrated that large colonies (.2 mm) have a
greater proliferative potential and exhibit all of the key tissue
culture stem cell characteristics (extensive self-renewal, generation
large number progeny and multi-lineage differentiation potential)
compared to smaller colonies (which do not exhibit these stem cell
criteria). Therefore, the N-CFCA provides a method to enumerate
neural stem cells frequency [21].
To support the mathematical modeling of the NSA with
biological experiments we have compared the culturing and
expansion of embryonic and adult murine NSCs in conditions that
result in different growth rates (i.e. different fold expansion
implying different stem cell self-renewing symmetric division rate).
While the NSA model does not allow us to accurately quantify
numbers of stem cells (due solely to fact that we do not know how
many stem cells we started with), it does allow a comparison
between groups of populations of the stem cell expansion rate,
which reflects the frequency of symmetric stem cell division. In this
particular case we compared the cell fold expansion of the
following conditions (Table 1): (Group1) Fetal E14 NSC cultures
vs. Aged adult (20 months) NSC cultures, (Group 2) Fetal E14
NSC cultures with the mitogen EGF vs. the use of EGF + bFGF,
(Group 3) Adult NSC cultures with the mitogen EGF vs. the use of
EGF + bFGF. From these measures the effective stem cell
symmetric division rate (Kll) was derived (Table 1). Fetal stem cells
cultured with both growth factors exhibited a 7.16-fold increased
expansion rate compared to 24-months old stem cells cultured
with EGF alone (group 1) and a 1.33-fold difference compared to
the fetal cultures exposed to EGF alone (group 2). Group 3
displayed a 1.57-fold difference between the two conditions. These
differences within the groups in the rate stem cells expanded was
correlated to the absolute numbers of stem cells measured using
the N-CFCA (Fig. 2) and the comparison results are shown in
Table 2. To test the assumption that both methodologies were
similar we compared the difference of their output to zero using
the Student’s t-test. The p value of the statistical test was 0.28
demonstrating that both assays predict a similar change in the
ratio of neural stem cell number or fold expansion (aka self-
renewing symmetric division rate), validating this mathematical
interpretation of the NSA.
Application of the model
We then used the model as a methodology for studying somatic
stem cell self-renewing symmetric division mechanism. Using the
N-CFCA, we previously showed that growth hormone receptor
knock out (GHR 2/2) mice exhibited significantly fewer
periventricular region derived stem cells as compared to wild type
Stem Cell Symmetric Division and Sphere Assays
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compared to wild type neural stem cells, GHR 2/2 NSCs
expanded at a significant lower rate (2.0460.2 vs 3.6360.4,
Fig. 3a) [25] correlated to a decreased self-renewing symmetric
division rate (Fig. 3b). Once again, both assays predicted the same
ratios between the two populations (1.74 and 1.78 for the N-CFCA
and the NSA respectively) [24]. These results suggest that growth
hormone signaling controls the self-renewal of somatic neural stem
cells by regulating their symmetric division rate. Pluchino and
colleagues described the inhibitory effect of chronic inflammation
on stem cell self-renewal [26]. This study reported that exposure of
adult subventricular zone derived stem cells to inducing-inflam-
mation Th1 cytokines caused a significant decrease in the number
of NSCs measured with the N-CFCA and that this phenomenon
was accompanied with a diminution of the slope of the growth
curve [26]. These data further validate our mathematical
interpretation of the neurosphere assay and support the model
where Th1 cytokines down-regulate somatic adult stem cell
expansion rate via symmetric cell division related mechanism.
The math model could also be applied to cancer biology.
Several types of cancer, including those of the breast and CNS,
contain cells exhibiting stem-like cell features such as long-term
repopulating property [10,14,16,27]. The cancer stem cell
hypothesis states that tumors are hierarchically organized and
maintained by a distinct subpopulation of long-term repopulating
cancer stem-like cells providing therapeutic refractoriness proper-
ties. Therefore, understanding the dynamic of these cells is of great
interest to understand cancer biology and to design innovative and
specific treatments. We used our model to compare cancer stem-
like cell (aka LTP cancer cells) self-renewing symmetric division
frequency and tumor progression between several adult human
glioblastoma multiforme (hGBM) cell lines grown in the Neuro-
sphere assay conditions [16]. The three different hGBM samples
analyzed (A, B and C) and generated in our laboratory exhibited
distinct expansion profiles (reflected by different slopes of the
curve) and LTP cancer cell symmetric division rates (Fig. 3c–e).
Orthotopic transplantation of 200,000 cells from hGBM samples
A, B and C into the striatum of immuno-compromised mice led to
tumor formation followed by death of the animals (Fig. 3f).
Importantly, the disease progression was directly and inversely
correlated with the self-renewing symmetric division rate of the
LTP cancer cells. This was expressed by comparing the mean
survival of host animals implanted with one of the three hGBM
tumor stem cell lines to the LTP cancer cell symmetric division
rate (Kll) (Fig. 3g).
In addition to brain tumors we have applied our model to breast
cancer. We cultured and propagated in vitro three different breast
tumor cell lines (KPL-1, MCF-7 and BT-474 named respectively
line A, B, and C) by applying similar culture conditions used for
the NSA. We used serum free medium containing human
epidermal growth factor (rhEGF) and basic fibroblast growth
factor (rhbFGF) allowing breast tumor cells to grow and form
spherical non-adherent mammospheres [11,19], measured the fold
expansion of the breast cancer lines over six to eight passages and
calculated their respective Kll (Fig. 4a–b). Our mathematical
model of the mammosphere assay predicts a rate of LTP cancer
Table 1. Symmetric cell division rate.
Groups 1 2 3
E14-EGF + bFGF 24 months-EGF E14-EGF E14-EGF + bFGF Adult-EGF Adult- EGF + bFGF
F 22.2 3.1 13.6 18.1 8.0 12.6
Time (days) 7 10 7 7 7 7
Kll (divisions/day) 0.44 0.11 0.37 0.41 0.30 0.36
NSCs harvested from ganglionic eminences of E14 mice or from the periventricular region of adult mice were cultured with EGF and bFGF or with EGF alone
respectively. The fold expansions (F) were compared, from which the effective rate of stem cell symmetric division (Kll) was calculated using the time for a passage.
doi:10.1371/journal.pone.0015844.t001
Figure 2. Math model validation: the Neural Colony Forming Cell Assay (N-CFCA). Cells from each group were cultured in the N-CFCA. The
graphs compare in each group, the number of large colonies, greater than 2 mm in diameter (the only size range exhibiting all the key tissue culture
stem cell features) obtained after 21 days in vitro. *p=0.039, **p=5.38610
211, n=15, t-test, 2 tails.
doi:10.1371/journal.pone.0015844.g002
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6 cells of each breast
tumor cell line were transplanted under the skin of immuno-
compromised mice and formed tumors at different rate (Fig. 4c).
Similar to brain tumor experiments, cell lines exhibiting higher
LTP cancer cell symmetric division rate led to faster tumor
progression combined with poorer survival as demonstrated in the
graph comparing Kll to the mean survival of the transplanted
animals (Fig. 4c–d).
Altogether these results suggest that the LTP cancer cell self-
renewing symmetric division rate measured in vitro using Sphere
Assays can be used to predict tumor progression based on the
notion that increased self-renewing symmetric divisions of the LTP
cancer cells will produce more tumor initiating cells resulting in a
more aggressive tumor. These data also validate the potential
application of our model in cancer and support the significance of
the malignant LTP cell compartment in driving the expansion of
the tumor and influencing the disease outcome.
The model can also be used to identify agents that specifically
target the LTP cancer cell population vs. those that target the STP
cancer cell population. Previously we had shown that exposure of
cultured hGBM to BMP4 reduces the Kll suggesting that it is
targeting the LTP cancer cell population (i.e. cancer stem cells),
which was confirmed by a significant reduction in the ability of
BMP4 treated hGBM cells to initiate tumor formation in
immunocompromised hosts [17]. Here we have extended this
paradigm, using the model to identify agents that may or may not
target the STP cancer cells (i.e. progenitor cells). Transforming
growth factor beta 2 (TGFb2), known primarily for its growth-
inhibitory properties, is both a suppressor and promoter of
tumorigenesis, producing a malignant phenotype in tumor-derived
cells in culture and exhibiting high expression levels in advanced
tumors [28]. Addition of TGFb2 to hGBM tumor cell cultures
resulted in an increase in the number of sphere-initiating cells
(Fig. 5a). However TGFb2 had no significant effect on the fold
expansion and the rate of LTP cancer cells self-renewing
symmetric divisions based on modeling of serial passage data
(Fig. 5b–c). Based on the significant increase in the number of
sphere forming cells, and in the absence of applying the math
model, one would have interpreted the data to imply that TGFb2
increased the proliferation of tumor initiating cells (i.e. LTP cells),
while in fact it appears to not affect this population. Our data
confirm the proliferative effect of TGFb2 described in the
literature [28,29] but suggests that it drives the proliferation of
STP cancer cells (or progenitor cells) as opposed to LTP cancer
cells (aka cancer stem cells). Although TGFb2 specifically
increased the pool of STP cancer cells in culture, as expected, it
did not enhance the tumor progression when the cells were
transplanted either subcutaneously (Fig. 5d) or intracranially
(Fig. 5e), as TGFb2 did not increase the number of LTP tumor-
initiating cancer stem cells. This is in line with the notion that the
LTP cancer cell sub-population is associated to the ability of a
population of cells to initiate and drive tumor progression and
further supports a direct correlation between the rate LTP cancer
cell expand in vitro and the aggressiveness of the tumor in vivo.
Together these results indicate the meaningful potential of the
use of our model in studies aimed at identifying genes or molecules
that regulate somatic and cancer stem cell activity.
Discussion
The discovery of stem cells in the mature mammalian nervous
system opened the door to the design and development of
therapeutics to replace cells lost to injury or disease [4,30]. Central
to this approach is a detailed understanding of the mechanisms that
drive NSC division and differentiation of their progeny in the context
of different disease states. However, while assays exist to evaluate the
division of precursor cells both in vivo ( i . e .B r d U ,K i 6 7 ,l a b e lr e t e n t i o n )
and in vitro (BrdU, cell counts, sphere forming assays) unraveling the
contribution of stem cells from progenitor cells is difficult due to the
lack of specific stem cell markers [31]. While functional assays have
been widely used for assessing stem cell activity both within [7] and
outside [32] the CNS, they are also fraught with difficulties related to
an ambiguous read-out [20]. We have previously addressed this
dilemmabydevelopinganassay(Neural-ColonyFormingCellAssay)
that is a hybrid of the tried and true classic hematopoietic precursor
cells assays [32] and the NSA [4], and utilizes the extensive
proliferative ability of neural stem cells relative to progenitor cells
[21]. Here we report on the development, validation and application
of a mathematical model that takes advantage of a peculiarity of the
NSA (majority of the cells die at passage except for the growth factor
responsive sphere forming cells) and allows us to estimate the relative
variation in the frequency of LTP cells in this culture system. While
we make the assumption that LTP cellsare equivalent to NSCs, this is
notwithoutwarrant,giventhatthisfeatureisadefiningcharacteristic,
distinguishing stem cells from other types of proliferating precursors
[21,33,34,35]. We also contend that the model provides a sensitive
meaningful read-out of self-renewing symmetric NSC division, as
expansion of this population is dependent on this mode of division.
Practically, the model can be used as a metric to compare the effects
of genetic and epigenetic influences on self-renewing symmetric
somatic NSC and cancer stem cell division, thereby allowing the
identification of agents that can be used to increaseand decrease stem
cell numbers, respectively.
The neurosphere assay has been shown to be useful for somatic
and cancer stem cell studies (for review [18]). The specific
molecular and biochemical dissection of stem cell self-renewal and
differentiation mechanisms have been hampered due to the
heterogeneous nature of the neurosphere assay. Thus the free-
floating culture system contains a mixed population of cells at
various stages of commitment with this heterogeneity increasing
with sphere size. To overcome the cellular complexity observed in
this assay, adherent culture systems have been employed to isolate
and expand somatic and cancer stem cells [36,37] with the intent
of providing a less heterogeneous population [38]. Notwithstand-
ing, our mathematical modeling overcomes the barriers created by
the heterogeneous cellular composition within the NSA by using a
simple algorithm that enables rigorous and specific assessment of
the behavior of the stem cell compartment based on bulk
population analysis.
To explore and understand the complexity of a biological
system and to overcome the inherent limitations of biological
experiments, mathematical modeling and computer simulation
Table 2. Comparison of the results obtained from the
mathematical modeling (F) and the N-CFCA (stem cell
number).
Comparison
Math Model
(Ratio Fold Expansion)
N-CFCA (Ratio numbers
of Large Colonies)
Group 1 7.16 8.98
Group 2 1.33 1.70
Group 3 1.57 1.50
Both assays predict the similar ratios between the two populations compared in
each group.
doi:10.1371/journal.pone.0015844.t002
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models have been proposed to provide tools to test key
mechanisms at the cellular level that link the somatic/tumor stem
cell compartment to tissue function and dysfunction. In the field of
cancer, math modeling is not a new concept and has been used
since the 1950’s [40]. For example, Boman and colleagues
Figure 3. Application of the math modeling. (a–b) Compared to wild type animals, GHR2/2 neural stem cells exhibited lower expansion rate (a,
**p=0.005, n=7, t-test, 2 tails), which was correlated to a decreased symmetric cell division frequency (b, **p=0.003, n=7, t-test, 2 tails).
(c–d) Comparison of the growth in the neurosphere assay of three human GBM samples showed distinct fold expansions (c) andslopes of growth curve
(d). t-test (2 tails) was used to compare the fold expansion between lines A and B (***p=1.4610
26, n=8–9), lines A and C (**p=1.4610
25, n=8–6) and
lines B and C (*p=0.001, n=9–6). (e) The LTP cancer cell symmetric division frequency (Kll) was derived from the fold expansion observed at each
passage. t-test(2 tails) was used to compare the Kll betweenlines A andB (***p=8.34610
212, n=8–9), lines A andC (**p=1.66610
28, n=8–6) andlines
B and C (*p=0.002, n=9–6). (f) Survival analysis after implantation into the striatum of NOD/SCID mice of 200,000 cells from three different tumor cell
lines demonstratedaninverse relationship between the rate of symmetric divisionof thelong-termproliferative cancer cell andthedisease progression.
Logrank test, p=0.0038 comparing A to B, p,0.0001 comparing A to C and B to C. (g) The graph represents the mean survival after hGBM intracranial
transplantationas a function of the rate LTP cancer cellsundergone symmetric division(Kll). Thedashedlines correspond to the 95% confidence band of
the fit curve obtained by nonlinear regression (y=2.323 – 0.2091x +0.005125x
2). Coefficient R
2 and p value are also shown.
doi:10.1371/journal.pone.0015844.g003
Stem Cell Symmetric Division and Sphere Assays
PLoS ONE | www.plosone.org 7 January 2011 | Volume 6 | Issue 1 | e15844described a kinetic model of a colonic crypt with the hypothesis
that tumor formation in the colon is governed by crypt stem cell
pool overpopulation via an increase in symmetric division [35,41].
They proposed three distinct compartments - the stem cell fraction
with a theoretical unlimited self-renewal capacity, the progenitor
pool which displays limited renewal capacity and finally the
differentiated compartment, with cells having no proliferative
ability and a finite life span. The paradigm considers that stem
cells are at the top of the cellular hierarchy and that the total
population size remains stable overtime in normal colonic crypt,
consistent with steady state conditions. The central tenet of this
model is that the long-term renewable population (aka stem cells)
assures tissue homeostasis and that only changes in the dynamic of
the stem cell pool, via perturbation of their symmetric division
rate, can account for the biologic characteristic of colorectal
cancer development and progression [35]. Similarly, supported by
numerical simulation, Dingli et al. modeled the response to
treatments regarding the hierarchy and dynamic of the physio-
logical or neoplastic hematopoietic system involving somatic and
cancer stem cells. They tested several therapeutic scenarios
demonstrating the critical need to target specifically the stem cell
load for successful therapy [40]. As opposed to these examples of
theoretical models testing the influence of hypothetic scenarios
that involved kinetic changes in the stem cell pool using numerical
simulation, our model is a mathematical interpretation of
experimental observations enabling effective measurement of a
specific cellular compartment (i.e. LTP cells) known to govern
tissue homeostasis or oncogenesis.
The ability to predict LTP cell symmetric division rate using the
sphere assay math model was experimentally tested using the
NCFCA. This assay was chosen due to its aptitude to quantify
specific changes in the neural stem cell compartment based on the
notion that progenitor cells show a restricted proliferative potential
compared to stem cells that have a more unlimited proliferative
ability. Hence, these two populations can be distinguished based
on the size of the colony they generate. Using this methodology we
were able to correlate a comparison of the actual stem cell
frequency (N-CFCA) (fig. 2) with stem cell expansion rate (related
to symmetric division rate, in our math model) under different
experimental circumstances (Table 1). We found corresponding,
nearly identical (non-significant) changes in the size of the stem cell
pool in both assays (Table 2). Although we validated our
mathematical modeling using an in vitro assay, its direct correlation
to physiological in vivo measurements (fig. 3 and 4) supports that
the model is rooted in biologically reasonable assumptions. Due to
its simplicity and robustness the mathematical interpretation
presented in this manuscript provides meaningful and compelling
information about stem cell frequency and the rate these cells
expand via symmetric division. As stem cells fundamentally
contribute to tissue homeostasis in adults and because stem-like
cells within some cancers are hypothesized to be a critical
component of malignancy, validation of our model enabling direct
assessment of somatic/cancer stem cell dynamics provides metric
to better understand the biology of stem cell division. For instance,
in validating the model we assessed the effects of mitogens (EGF
and FGF) and age on symmetric NSC divisions. Our model
predicted 57% increase in expansion rate when adult mouse
neural stem cells were cultured with both EGF and bFGF
compared to EGF alone (Table 1, group 3). These changes were
confirmed by a 50% increase in neural stem cell frequency
measured with the NCFCA (fig. 2, group 3). Similarly the math
model prediction of a 87% decrease in neural stem cell expansion
rate as a process of aging (Table 1, group 1), which was confirmed
by the 89% decrease in neural stem cell frequency in the 24-
months cultures compared to the embryonic cultures (fig. 2, group
1). Additionally, data mining in the current scientific literature
corroborated the relationship between the output of the NCFCA
and the stem cell expansion rate obtained using the NSA, hence
further supporting the validity of our math model [26]. Not only
providing a renewable source of cells for neurodegenerative
disease studies, the NSA presents a suitable system for pharma-
ceutical and neurotoxicological screening aiming at designing new
therapeutic approaches to target the self-renewal capacity that is
essential for controlling the stem cell pool. Finally, measuring
symmetric cancer stem cell (i.e. LTP cancer cells) division provides
a tool to study tumor biology as well as to test effect of drugs on
this particular cellular compartment that may be responsible for
tumor resistance and driving long-term tumor growth (fig. 3 and 4)
[15,33,42,43,44,45,46].
Validation of the math model supports use of this methodology
as a tool that can be used for the discovery of exogenous signaling
agents and endogenous genetic elements that specifically or
generally regulate the stem cell compartment. Understanding,
from a functional point of view, stem cell regulatory signaling
provides bases for rational drug discovery aimed at treating
diseases that result in cell loss or disorders that can benefit from the
generation of new cells. In addition, aging is known to adversely
affect the stem cell pool outside of the CNS, identifying
pharmaceuticals and nutraceuticals that can preserve the func-
tional aspects of the NSC compartment may have an important
outcome in reducing the burden of age-related CNS degeneration.
In addition, our model may find application in cancer biology. It is
Figure 4. Application of the model to breast cancer. (a–b) Three
breast cancer cell lines were cultured in the mammosphere assay. In
these conditions the 3 cell lines displayed different expansion rate and
LTP cell symmetric division frequency. **p,1610
25, t-test, 2 tails,
n=36–48. (c) Tumor growth was monitored overtime between the 3
groups from which survival analysis was performed and graphed as
percentage of animals that have not reach the maximal tumor size
(520 mm
3) as a function of time. Logrank test, p,0.0001 comparing the
three populations to each other, n=10. (d) Similar to hGBM, tumor
progression after breast cancer cell s.c. transplantation was directly and
inversely correlated to the symmetric division rate of the LTP cancer
cell. The dashed lines correspond to the 95% confidence band of the fit
curve obtained by nonlinear regression (y=0.1743 – 0.001123x –
0.00002258x
2). Coefficient R
2 and p value are also shown.
doi:10.1371/journal.pone.0015844.g004
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contain cells exhibiting stem cell characteristics and that this
population and their unique properties may contribute to tumor
progression and treatment resistance. Enumerating this population
and quantifying the effect(s) of treatment is difficult as stem cells
(both normal and malignant) are defined by function. While single
and combination of markers have been useful, their validity, when
it comes to accurately defining the entire cancer stem cell pool, has
been challenged [47]. Methodologies that are able to functionally
measure symmetric cancer stem cell (LTP) division under a variety
of experimental conditions will benefit the targeting of this
component, which is important for cancer stem cell expansion.
In this study we positively correlate the LTP cell expansion rate
with GBM and breast tumor progression in vivo, and demonstrate
how the Sphere Assay mathematical model can be used as readout
for agents that specifically reduce or eliminate the tumor stem cell
pool. Hence, our method can be used to detect and grade the
occurrence of the LTP cancer cells and to study their contribution
to the maintenance and therapy resistance of the tumor. Hence
our modeling not only provides insight into cell kinetics
mechanism leading to tumor growth, but as well has significance
for elaboration of new approaches toward cancer treatment.
Materials and Methods
Ethics Statement
Animal studies were approved by the University of Florida
Institutional Animal Care and Use Committee (IACUC, Permit
Number: 2008-01502) and the University of Queensland Animal
Ethics Committee (UQAEC, Permit Number: QIMR-P1159).
The use of human samples in this study was approved by the
University of Florida Institutional Review Board (IRB Project #
127-2009). Written informed consent was provided by all
participants.
Mouse neural stem cell culture
Neural stem cells harvested from ganglionic eminences of E14
wild type mice or from the periventricular region of adult mice
(wild type or growth hormone receptor knock out) were cultured
with EGF and bFGF or with EGF alone for 6 to 7 passages in the
neurosphere assay as described in [21].
The neural colony forming cell assay method
After 4 passages in the NSA, the different groups of cells [fetal
E14 NSCs, aged adult (20 months) NSC and adult NSCs cultured
with different combination of mitogens, EGF and bFGF or EGF
alone] were cultured in the Neural Colony Forming Cell Assay as
described in [21].
Primary cell culturing and propagation of human
glioblastoma
Cells were isolated from human glioblastoma (hGBMs) as
described [16] and cultured in the neurosphere assay supplement-
ed with with 20 ng/ml hEGF, 10 ng/ml basic fibroblast growth
factor, and 2 mg/ml heparin. To measure the effect of TGFb2o n
the symmetric division rate of the LTP/STP cancer cells, the
treatment was performed by adding 100 ng/ml of TGFb2t o
growth medium at every passage for 4 passages.
Xenotransplantation of brain tumor cells
The tumorigenicity of hGBM cells was measured in vivo after
intrastriatal or subcutaneous injection (s.c.) using non-obese
diabetic/severe combined immunodeficient mice (NOD/SCID).
Figure 5. TGFb2 does not change the long-term proliferating cell self-renewal. (a) Addition of TGFb2 to hGBM cells cultured in the
neurosphere assay induced an increase in the number of spheres (**p=0.0003, n=5, t-test). Application of 100 ng/ml of TGFb2 to serial passed
cultures did not change the expansion rate (p=0.623, n=4, t-test) (b) and the symmetric division rate (Kll) of the tumor long-term proliferative cancer
cells (p=0.645, n=4, t-test) (c). TGFb2 treatment did not enhance tumor progression of hGBM cells transplanted subcutaneously (p=0.236, Log rank
Test) (d) or intracranially (p=0.158, Log rank Test) (e).
doi:10.1371/journal.pone.0015844.g005
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(Materials and Methods S1).
Propagation and Culture of Mammospheres from
Established Breast Cancer Cell Lines
First, our breast cancer cell lines (A=KPL-1, B=MCF-7 and
C=BT-474) were cultured in adherent/monolayer conditions
[48]. For culturing cells as spheres we have used the mammo-
sphere assay based upon culturing neural stem cells in serum-free
medium containing recombinant human epidermal growth factor
(rhEGF) and basic fibroblast growth factor (rhbFGF) [11,19].
Mammosphere culture protocol is detailed in the supplemental
data (Materials and Methods S1).
Breast cancer cell transplantation
6–8 week old NOD.Cg-Rag1
tm1MomIl2rg
tm1Wjl/SzJ mice (The
Jackson Laboratory, Bar Harbor, Maine, USA) were used for the
subcutaneous (s.c.) injections of breast cancer cells. Transplanta-
tion paradigm is described in supplemental data (Materials and
Methods S1).
Supporting Information
Materials and Methods S1
(DOC)
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